Hydrochlorothiazide; Valsartan is Used for treating high blood pressure. It was first introduced by Novartis Pharmaceuticals Corp in its drug Diovan Hct on Mar 6, 1998. 11 different companies have introduced drugs containing Hydrochlorothiazide; Valsartan.

Hydrochlorothiazide; Valsartan Patents

Given below is the list of patents protecting Hydrochlorothiazide; Valsartan, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Diovan Hct	US6294197 (Pediatric)	Solid oral dosage forms of valsartan	Dec 18, 2017 (Expired)	Novartis
Diovan Hct	US6294197	Solid oral dosage forms of valsartan	Jun 18, 2017 (Expired)	Novartis
Diovan Hct	US5399578 (Pediatric)	Acyl compounds	Sep 21, 2012 (Expired)	Novartis

Add above patents to watchlist

Hydrochlorothiazide; Valsartan's Family Patents

Full family tree

Hydrochlorothiazide; Valsartan Generic API Manufacturers

Several generic applications have been filed for Hydrochlorothiazide; Valsartan. The first generic version for Hydrochlorothiazide; Valsartan was by Mylan Pharmaceuticals Inc and was approved on Sep 21, 2012. And the latest generic version is by Amneal Pharmaceuticals Of New York Llc and was approved on Aug 11, 2023.

Given below is the list of companies who have filed for Hydrochlorothiazide; Valsartan generic, along with the locations of their manufacturing plants worldwide.